References
- Nachtigall MJ, Smilen SW, Nachtigall RD, Nachtigall RH, Nachtigall LE. Incidence of breast cancer in a 22-year study of women receiving –progestin. Obstet. Gynecol. 80, 827–830 (1992).
- Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. The Women's Health Initiative Steering Committee. JAMA 291, 1701–1712 (2004).
- Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA 288, 49–57; Erratum 1064 (2002).
- Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280, 605–613 (1998).
- Eisen A, Lubinski J, Klijn J et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case control study. J. Clin. Oncol. 23(30), 7491–7496 (2005).
- Schairer C, Lubin J, Troisi S, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen–progestin replacement therapy and breast cancer risk. JAMA 283, 485–491; 284, 2597 (2000).
- Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am. J. Epidemiol. 152, 950–964 (2000).
- Archer DF. Lower doses of oral estrogen and progestogens as treatment for ostmenopausal women. Semin. Reprod. Med. 23(2), 188–195 (2005).
- Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419–427 (2003).
- Guidozzi F. Estrogen replacement therapy in breast cancer survivors. Int. J. Gynaecol. Obstet. 64(1), 59–63 (1999).
- Vassilopoulou-Sellin R, Asmar L, Hortobagvi GN et al. Estrogen replacement therapy after localized breast cancer. J. Clin. Oncol. 17, 1482–1487 (1999).
- Holmberg L, Anderson H, for the HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. Lancet 363(9407), 453–455 (2004).
- Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701–1712 (2004).